8-KOther Events

BRISTOL MYERS SQUIBB CO 8-K Report, Corporate Update (Aug 10, 2023)

Filed August 10, 2023For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) announced on August 9, 2023, that it has entered into accelerated share repurchase (ASR) agreements to buy back an aggregate of $4.0 billion of its common stock. These transactions are part of a previously authorized multi-year share repurchase program and are being executed with major financial institutions including Bank of America, Citibank, JPMorgan Chase, and Morgan Stanley. The ASR transactions are designed to return capital to shareholders and reflect the company's confidence in its financial position and future prospects. While an initial portion of the shares will be delivered promptly, the final number of shares repurchased will be determined by volume-weighted average prices over the repurchase period, with potential adjustments. This move is a significant capital allocation decision that investors will want to monitor for its impact on earnings per share and overall shareholder value.

Key Highlights

  • 1BMY is initiating $4.0 billion in Accelerated Share Repurchase (ASR) transactions.
  • 2These repurchases are part of a previously announced multi-year share buyback program.
  • 3The ASRs are executed with major financial institutions: Bank of America, Citibank, JPMorgan Chase, and Morgan Stanley.
  • 4An initial portion of shares will be repurchased at 85% of the $4.0 billion repurchase price based on the August 9, 2023 closing price.
  • 5The final number of shares repurchased will be based on volume-weighted average prices, subject to potential adjustments.
  • 6The ASR transactions are scheduled to conclude in the fourth quarter of 2023, but may terminate earlier at the banks' discretion.

Frequently Asked Questions

An Accelerated Share Repurchase (ASR) is a transaction where a company buys back its own stock from a financial institution. It allows the company to quickly reduce its outstanding shares and return capital to shareholders. A portion of the shares is usually delivered immediately, with the final amount determined later based on market prices.

This significant share repurchase program indicates that BMY's management believes its stock is undervalued and represents a favorable use of capital. It's also a way to return value directly to shareholders and potentially boost earnings per share (EPS) by reducing the number of outstanding shares.

The final number of shares to be repurchased will be determined based on the volume-weighted average prices of BMY's common stock during the term of the ASR transactions. There are also provisions for adjustments, which means the final count could differ from initial estimates.

By repurchasing $4.0 billion worth of stock, BMY will reduce its cash on hand. However, it will also decrease the number of outstanding shares, which can lead to an increase in earnings per share (EPS) and potentially a higher stock price if the market views the repurchase favorably. The company's debt-to-equity ratio may also be affected.